Fluorouracil, epirubicin, and cyclophosphamide with either docetaxel or vinorelbine, with or without trastuzumab, as adjuvant treatments of breast cancer: final results of the FinHer Trial (Q43250043)
Jump to navigation
Jump to search
scientific article published on 2 November 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Fluorouracil, epirubicin, and cyclophosphamide with either docetaxel or vinorelbine, with or without trastuzumab, as adjuvant treatments of breast cancer: final results of the FinHer Trial |
scientific article published on 2 November 2009 |
Statements
1 reference
Fluorouracil, epirubicin, and cyclophosphamide with either docetaxel or vinorelbine, with or without trastuzumab, as adjuvant treatments of breast cancer: final results of the FinHer Trial (English)
1 reference
1 reference
Taina Turpeenniemi-Hujanen
1 reference
Jorma Isola
1 reference
Pirkko-Liisa Kellokumpu-Lehtinen
1 reference
Petri Bono
1 reference
Riitta Kokko
1 reference
Päivi Auvinen
1 reference
Leena Helle
1 reference
Raija Asola
1 reference
Marjo Pajunen
1 reference
Sirkku Jyrkkiö
1 reference
Tapio Utriainen
1 reference
Tuomo Alanko
1 reference
Kari Möykkynen
1 reference
Seija Ingalsuo
1 reference
Mauri Huusko
1 reference
Tapio Salminen
1 reference
Hannu Leinonen
1 reference
Mika Leinonen
1 reference
2 November 2009
1 reference
1 reference
Identifiers
1 reference